Who gets Prostate cancer?

['ⵙⵎⴷ ⵜⴰⴱⵔⴰⵜ ⴰⴷ']

ⵎⴰⵏⵉ ⵉⵍⴰⵏ ⴽⴰⵏⵚⵉⵔ ⵏ ⴱⵔⵓⵙⵜⴰⵜ?

ⴰⵛⴰⵔⵢⵗⴰ ⵏ ⴱⵔⵓⵙⵜⴰⵜ ⵢⵈⵈⴰⵍ ⴰⵛⵂⴰⵔⵢⵗⴰ ⵉⵋⵋⴰⵏ ⵋⵉⵔ ⵉⵔⴳⴰⵣⴰⵏ, ⵙ ⵉⵋⵋⴰⵛⵂ ⵏ ⵔⵢⵣⴾⵓ ⵉⴷ ⴰⵓⴰⵜⴰⵉ

ⴷⴰ ⵉⵜⵜⵓⵙⵜⴰⵍ ⵡⴰⵍⴰ ⵖⵓⵔ ⵉⵔⴳⴰⵣⵏ ⵉⵍⴰⵏ ⵓⴳⴳⴰⵔ ⵏ 65 ⵏ ⵓⵙⴳⴳⵡⴰⵙ.

ⴽⵔⴰ ⵏ ⵉⵎⵙⴽⴰⵔⵏ ⵏⵏⴰ ⵉⵖⵉⵏ ⴰⴷ ⵙⵙⵉⴷⵔⵏ ⴰⵙⵓⵔⵙ ⵏ ⵓⴱⵓⵖⵍⵓ ⵏ ⵍⴽⵏⵚⵉⵔ ⵏ ⵜⴰⴱⵔⵓⵜⵉⵙⵜⴰⵜ ⴳⴰⵏ:

1. ⴰⵍⵆⵉⴷⵎⴰⵜ: ⵆⴰⵔⴰⴷ ⵓⴰⵏ ⴾⴰⵏⵛⵢⵔ ⵓⴰⵏ ⴱⵔⵓⵙⴰⵜⵢⵜ ⵉⵋⵋⴰ ⴼⴰⵍ ⴰⵍⵆⵉⴷⵎⴰⵜ, ⴷⴰⵔⴰⵜ ⵎⴰⵈⵈⵓⵔⴰⵏ ⵏ ⵉⵛⵂⵉⴾⵉⵍⴰⵏ ⵉⵍⵍⴰⵏ ⴷⴰⵗ ⵉⵔⴳⴰⵣⴰⵏ ⵓⵉⵏ ⵓⴶⴰⵔ 65 ⵏ ⴰⵓⴰⵜⴰⵉ

2. ⴰⵎⵣⵔⵓⵢ ⵏ ⵜⴰⵡⵊⴰ: ⵉⵔⴳⴰⵣⵏ ⵉⵍⴰⵏ ⴰⵎⵣⵔⵓⵢ ⵏ ⵜⴰⵡⵊⴰ ⵏ ⵍⴽⵓⵏⵚⵉⵕ ⵏ ⵓⴱⵔⵓⵜⵉⵙⵜ, ⵙ ⵓⵥⵍⴰⵢ ⴱⴰⴱⴰⵙ ⵏⵖⴷ ⵓⵍⵜⵎⴰⵜ ⵉⵍⴰⵏ ⵜⵎⴰⴹⵓⵏⵜ, ⵖⵓⵔⵙⵏ ⵜⵉⵍⵉⵜ ⵜⴰⵅⴰⵜⴰⵔⵜ ⵏ ⵓⴱⵓⵖⵍⵓ ⵏ ⵍⴽⵓⵏⵚⵉⵕ ⵏ ⵓⴱⵔⵓⵜⵉⵙⵜ.

3. ⵜⴰⵡⵙⵉⵜ: ⵉⵔⴳⴰⵣⵏ ⵉⵎⴰⵣⵉⵖⵏ ⴳ ⵍⵍⴰⵏ ⵖⵓⵔⵙⵏ ⵜⵉⵍⵉⵜ ⵉⴳⴳⵓⵜⵏ ⴳ ⵓⴱⵓⵖⵍⵓ ⵏ ⵍⴽⵓⵏⵚⵉⵕ ⵏ ⵓⴱⵔⵓⵜⴰⵙⵉⵜ ⴷ ⵉⵖⵢ ⴰⴷ ⵜⵜⵓⵙⵏⴼⴰⵍⵏ ⴳ ⵓⵣⵎⵣ ⵉⵄⵔⵔⵉⵎⵏ ⴷ ⵖⵓⵔⵙⵏ ⵜⴰⵍⵖⵉⵡⵉⵏ ⵉⴳⴳⵓⵜⵏ ⵏ ⵜⵎⴰⴹⵓⵏⵜ.

4. ⵊⵉⵏⵉⵜⵉⵛⵙ: ⴽⵔⴰ ⵏ ⵉⵎⵓⵜⵜⵉⵢⵏ ⵉⵊⵉⵏⵉⵜⵏ ⵉⵜⵜⵓⴽⴽⵓⵙⵏ, ⵣⵓⵏⴷ ⵡⵉⵏ ⴳ ⵊⵉⵏ BRCA1 ⴷ BRCA2, ⵖⵉⵏ ⴰⴷ ⵔⵏⵓⵏ ⴰⵙⵓⵔⵙ ⵏ ⵓⴱⵓⵖⵍⵓ ⵏ ⵍⴽⵓⵏⵚⵉⵕ ⵏ ⵓⴱⵔⵓⵜⵉⵙⵜ.

5. ⴰⵎⵙⴳⵏⴰⴼ: ⴰⵎⵙⴳⵏⴰⴼ ⵉⵍⴰⵏ ⴰⵟⵟⴰⵙ ⵏ ⵉⵚⵕⵓⴹⵏ ⴷ ⵉⴼⴰⵔⵙⵏ ⵏ ⵜⴰⵙⵙⴰⴽⵓⵜ ⵉⵍⴰⵏ ⴰⵟⵟⴰⵙ ⵏ ⵉⵙⵎⵎⴰⵎ ⵉⵖⵢ ⴰⴷ ⵉⵔⵏⵓ ⴰⵙⵓⵔⵙ ⵏ ⵓⴱⴰⵢⵢⵓⵕ ⵏ ⵓⴱⵕⵓⵚⵟⴰⵜ, ⵎⴰⵛⴰ ⴰⵎⵙⴳⵏⴰⴼ ⵉⵍⴰⵏ ⴰⵟⵟⴰⵙ ⵏ ⵜⵢⴰⴼⵓⵜⵉⵏ ⴷ ⵜⵣⵓⵊⵊⵓⵜⵉⵏ ⵉⵖⵢ ⴰⴷ ⵉⴽⴼⵍ ⴰⵙⵓⵔⵙ.

6. ⴰⴱⵣⴰⵣ: ⴰⴷⴷⴰⵢ ⵉⴳ ⵓⴽⵙⴰⵢ ⵏ ⵜⴼⴽⴽⴰ ⵏⵖⴷ ⴰⴱⵣⴰⵣ ⵉⵖⵢ ⴰⴷ ⵉⵔⵏⵓ ⴰⵙⵓⵔⵙ ⵏ ⵓⴱⵓⵖⵍⵓ ⵏ ⵓⴽⵏⵙⵉⵔ ⵏ ⵓⴱⵔⵓⵜⴰⵙⵜ, ⴷ ⴰⵡⴷ ⵜⵉⵍⵉⵜ ⵏ ⵓⴽⵏⵙⵉⵔ ⴰⴷ ⵉⴳ ⵓⴳⴳⴰⵔ ⵏ ⵓⵃⵔⵛ.

7. ⵉⵎⵙⴽⴰⵔⵏ ⵏ ⵜⵓⴷⵔⵜ: ⵉⵍⵉⵏ ⵉⵎⵙⴽⴰⵔⵏ ⵏ ⵜⵓⴷⵔⵜ, ⵣⵓⵏⴷ ⴰⵙⵉⴽⵙⵍ ⴷ ⵓⴷⵔⴰⵔ ⵏ ⵜⵡⵓⵔⵉ ⵜⴰⴷⵓⵙⴰⵏⵜ, ⵖⵉⵏ ⴰⴷ ⵔⵏⵓⵏ ⴰⵙⵓⵔⵙ ⵏ ⵓⴱⵓⵖⵍⵓ ⵏ ⵍⴽⴰⵏⵚⵉⵔ ⵏ ⵓⴱⵔⵓⵜⵉⵙⵜ.

ⵉⵇⵇⴰⵏⴷ ⴰⴷ ⵏⵙⵙⴽⵜⵉ ⵎⴰⵙⴷ ⵎⵇⵇⴰⵔ ⵖⵉⵏ ⵉⵎⵙⴽⴰⵔⵏ ⴰⴷ ⴰⴷ ⵙⵙⴷⵓⵙⵏ ⴰⵙⵎⵓⵙⵙⵓ ⵏ ⵓⴱⵓⵖⵍⵓ ⵏ ⵍⴽⴰⵕⵙⵜⴰⵏ ⵏ ⵜⵓⵔⵉⵏ, ⵎⴰⵛⵛ ⵓⵔ ⴷⴰ ⵙⴱⵓⵖⵍⵓⵏ ⴽⵓⵍⵍⵓ ⵉⵔⴳⴰⵣⵏ ⵉⵍⴰⵏ ⵉⵎⵙⴽⴰⵔⵏ ⴰⴷ ⵏ ⵓⴱⵓⵖⵍⵓ ⵏ ⵜⵎⴰⴹⵓⵏⵜ, ⴷ ⴽⵔⴰ ⵏ ⵉⵔⴳⴰⵣⵏ ⵓⵔ ⵖⵓⵔⵙⵏ ⵉⵍⵍⵉ ⴽⵔⴰ ⵏ ⵉⵎⵙⴽⴰⵔⵏ ⵏ ⵓⴱⵓⵖⵍⵓ ⴰⴷ ⵉⵜⵜⵓⵙⵙⴰⵏⵏ ⵙ ⵓⴱⵓⵖⵍⵓ ⵏ ⵍⴽⴰⵕⵙⵜⴰⵏ ⵏ ⵜⵓⵔⵉⵏ.

ⵜⵉⴼⵉⴼⵖⵉⵏ ⵏ ⵓⵣⵣⵔⴰⵢ ⵏ ⵜⵓⵔⵉⵏ ⴷ ⵓⵎⵔⴰⵔⴰ ⵏ ⵡⴰⵡⴰⵍ ⵅⴼ ⴽⵓ ⴰⵎⵙⴳⵏⴰⴼ ⴷ ⵓⵎⵙⵏⵉⵊⵊⵉ ⵉⵥⴹⴰⵕ ⴰⴷ ⵢⴰⵡⵙ ⴳ ⵓⵙⵙⵉⵏⴼ ⵏ ⵍⴽⵓⵏⵚⵉⵕ ⵏ ⵜⵓⵔⵉⵏ ⴳ ⵜⵉⵣⵉ ⵏ ⵣⵉⴽⴽ, ⵍⵍⵉⵖ ⵢⵓⴼⵏ ⴰⴷ ⵢⴰⴼ ⵓⵙⵏⵊⵉ.

['ⵉⵙⵓⵎⴰⵔ']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Shimodaira K, Nakashima J, Nakagami Y, Hirasawa Y, Hashimoto T, Satake N, Gondo T, Namiki K, Ohori M, Ohno Y: Prognostic Value of Platelet Counts in Patients with Metastatic Prostate Cancer Treated with Endocrine Therapy. Urol J. 2020, 17 (1): 42-49.

Advanced prostate cancer gets a new foe. Johns Hopkins Med Lett Health After 50. 2013, 25 (7): 8.

Vera Badillo FE: Metastatic prostate cancer gets into the biomarker era. Can Urol Assoc J. 2022, 16 (10): 333.

Gerard MJ, Frank-Stromborg M: Screening for prostate cancer in asymptomatic men: clinical, legal, and ethical implications. Oncol Nurs Forum. 1998, 25 (9): 1561-9.

McDowell ME, Occhipinti S, Chambers SK: The influence of family history on cognitive heuristics, risk perceptions, and prostate cancer screening behavior. Health Psychol. 2013, 32 (11): 1158-69.

Razzaghi MR, Mazloomfard MM, Malekian S, Razzaghi Z: Association of macrophage inhibitory factor -173 gene polymorphism with biological behavior of prostate cancer. Urol J. 2019, 16 (1): 32-36.

['ⴰⵙⴱⴷⵉⴷ: ⴰⵎⵙⵏⵉⵊⵊⵉ']

['ⴰⵙⵉⵜ ⴰⴷ ⵉⵜⵜⵓⴼⴽⴰ ⵖⴰⵙ ⵉ ⵓⵡⵜⵜⴰⵙ ⵏ ⵓⵙⵙⵍⵎⴷ ⴷ ⵓⵙⵏⵖⵎⵙ, ⵓⵔ ⵉⴳⵉ ⴰⵙⴼⴽ ⵏ ⵓⵎⵛⴰⵡⴰⵕ ⵏ ⵓⴷⵓⵙⵜⵓⵔ ⵏⵖⴷ ⵜⵡⵓⵔⵉⵡⵉⵏ ⵜⵉⵣⵣⵓⵍⴰⵏⵉⵏ.']

['ⵓⵔ ⵉⵇⵇⵉⵏ ⴰⴷ ⵉⵜⵜⵓⵙⵎⵔⵙ ⵓⵎⵍⴰⵏ ⵉⵜⵜⵓⴼⴽⴰⵏ ⴳ ⵓⵙⵎⵔⵙ ⵏ ⵓⵙⵎⵉⴳⵍ ⵏⵖⴷ ⵓⵙⵓⵊⵊⵉ ⵏ ⵜⵎⵓⴽⵔⵉⵙⵜ ⵏ ⵜⴷⵓⵙⵉ ⵏⵖⴷ ⵜⵎⴰⴹⵓⵏⵜ, ⴷ ⵡⵉⵏⵏⴰ ⵉⵔⴰⵏ ⴰⵙⵇⵇⵙⵉ ⴰⵎⵙⵏⵉⵊⵊⵉ ⴰⵡⵏ ⵉⵜⵜⵓⴼⴽⴰⵏ ⵉⵇⵇⴰⵏ ⴰⴷ ⵙⴰⵡⵍⵏ ⴷ ⵓⵎⵙⵏⵉⵊⵊⵉ ⵉⵜⵜⵓⵥⵍⴰⵢⵏ.']

['ⵙ ⵡⴰⵍⵍⵍⵉ ⵉⵜⵜⵓⵢⴰⵏⵏⴰ, ⵜⴰⵔⴰⵜⵙⴰ ⵏ ⵓⵏⵢⵓⵔⴰⵍ ⵏⵏⴰ ⵉⵜⵜⴰⴽⴽⴰⵏ ⵜⵉⵎⵔⴰⵔⵓⵜⵉⵏ ⵉ ⵉⵙⵇⵙⵉⵜⵏ, ⵓⵔ ⴷⴰ ⵜⵜⵉⵍⵉ ⴰⴽⴽⵡ ⵜⵓⵙⴷⵉⴷⵜ ⴳ ⵎⴰⴷ ⵉⵥⵍⵉⵏ ⵙ ⵓⵡⵏⵖ ⵏ ⵓⵟⵟⵓⵏ. ⵙ ⵓⵎⴷⵢⴰ, ⵓⵟⵟⵓⵏ ⵏ ⵎⴷⴷⵏ ⵉⵜⵜⵓⵙⵏⴼⴰⵍⵏ ⵖⴼ ⵜⵎⴰⴹⵓⵏⵜ ⵉⵥⵍⵉⵏ.']

['ⵚⵓⴰⵍ ⵙⵓⵍ ⴰⵙⵏⴰⵍ ⵏ ⵓⵊⵉⵊⵊⵉ ⵏⵏⴽ ⵏⵖⴷ ⴽⵔⴰ ⵏ ⵓⵎⵙⵙⵉⵡⵍ ⵏ ⵜⴷⵓⵙⵉ ⵢⴰⴹⵏ ⵉⵇⴱⵍⵏ ⴳ ⵎⴰⴷ ⵉⵥⵍⵉⵏ ⵙ ⵡⴰⴷⴷⴰⴷ ⵏ ⵜⴷⵓⵙⵉ. ⵓⵔ ⴰⴽⴽⵡ ⴰⴷ ⵜⵙⵙⴼⵍⴷ ⴰⵙⵏⴰⵍ ⵏ ⵓⵊⵉⵊⵊⵉ ⴰⵣⵣⵓⵍⴰⵏ ⵏⵖⴷ ⴰⴷ ⵜⵣⴰⵢⴷ ⴳ ⵓⵙⵓⵜⴳ ⵏⵏⵙ ⴰⵛⴽⵓ ⵏⵜⵜⴰⵜ ⴰⵢⴷ ⵜⵙⵙⵖⵔⴷ ⴳ ⵓⵙⵉⵜ ⴰⴷ. ⵎⴽ ⵜⵓⵔⴷⴰ ⴰⴷ ⵖⵓⵔⴽ ⵉⵍⵍⴰ ⵡⴰⴷⴷⴰⴷ ⵏ ⵜⴷⵓⵙⵉ ⵉⵣⵣⴳⵔⵏ, ⵙⵎⴷ 911 ⵏⵖⴷ ⴰⴷ ⴷⵉⴷⵜ ⵜⴰⵍⵙ ⴷⴰⵔ ⵜⴰⴷⴰⵍⴰ ⵏ ⵓⵣⵣⵔⴰⵢ ⵏ ⵣⵉⴽⴽ. ⵓⵔ ⵜⵍⵍⴰ ⵜⵓⵇⵇⵏⴰ ⵏ ⵓⵊⵉⵊⵊⵉ ⴷ ⵓⵎⵏⵉⴳ ⵙ ⵓⵙⵉⵜ ⴰⴷ ⵏⵖⴷ ⵓⵙⵎⵔⵙ ⵏⵏⵙ. ⵓⵔ ⴷⴰ ⵜⵙⴽⴰⵔ ⴱⵢⵓⵎⵉⴷⵍⵉⴱ ⵏⵖⴷ ⵉⵎⵙⵡⵓⵔⵉⵏ ⵏⵏⵙ ⵏⵖⴷ ⴽⵔⴰ ⵏ ⵓⵎⴷⵔⴰⵡ ⴳ ⵓⵙⵉⵜ ⴰⴷ ⴽⵔⴰ ⵏ ⵓⵙⵎⴷⵢⴰ, ⵙ ⵡⴰⵡⴰⵍ ⵏⵖⴷ ⵙ ⵓⵙⵏⵓⵎⵍ, ⴳ ⵎⴰⴷ ⵉⵥⵍⵉⵏ ⵙ ⵉⵏⵖⵎⵉⵙⵏ ⵉⵍⵍⴰⵏ ⴳ ⵓⴷⵖⴰⵔ ⴰⴷ ⵏⵖⴷ ⵓⵙⵎⵔⵙ ⵏⵏⵙ.']

['ⴰⵙⴱⴰⴷⵓ: ⵉⵣⵔⴼⴰⵏ ⵏ ⵓⴼⵓⵙ']

['ⴰⵛⵔⵓⵜ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ']

['ⵎⴽ ⵜⵛⵛⵉⵖⴰⵍⴷ ⵙ ⵜⵛⵛⵉⵢⵜ ⵎⴰⵙⴷ ⴽⵔⴰ ⵏ ⵜⵓⵎⴰⵢⵜ ⵏⵖⴷ ⵉⵙⵏⴼⴰⵔⵏ ⵏⵏⴰ ⵉⵜⵜⵓⴼⴽⴰⵏ ⴳ ⵡⴰⵙⵉⵜ ⵏⵏⵓⵏ ⵏⵖⴷ ⵜⵉⵙⵏⵙⵉ ⵏⵏⵓⵏ ⴷⴰ ⵉⴽⵛⵎⵏ ⴳ ⵉⵣⵔⴼⴰⵏ ⵏ ⵓⵣⵔⴼ ⵏⵏⵓⵏ, ⵜⵣⵎⵔⴷ ⴰⴷ ⵜⴰⵍⵙⴷ (ⵏⵖ ⴰⵎⴷⵢⴰⵣ ⵏⵏⴽ) ⴰⴷ ⵜⵙⵏⵎⵍⴷ ⵉ ⵡⴰⵙⵉⵜ ⵏⵏⵓⵏ ⵙ ⵓⵙⵓⵜⵔ ⵏ ⵓⵙⵙⵉⴷⴼ ⵏ ⵜⵓⵎⴰⵢⵜ ⵏⵖⴷ ⵉⵙⵏⴼⴰⵔⵏ, ⵏⵖⴷ ⴰⴷ ⵜⴱⴷⴷⴷ ⵜⵉⵍⵉⵜ ⵏⵏⵙⵏ.']

['ⵉⵏⴰⵓⴰⵏ ⴰⵂⴰⵏ ⴰⴾⵜⴰⴱ ⵙ ⴰⵍⴾⵉⵜⵜⴰⴱ ⵙ ⵎⵢⵍ (ⵉⴾⵉⴰⴷ ⵙ ⴰⴾⵜⴰⴱ "ⵎⵢⵍ" ⵉ ⵎⵢⵍ)']

['DMCA ⵜⵙⵙⵓⵜⵔ ⴰⵙⵎⵉⵙⵉ ⵏⵏⴽ ⵏ ⵓⵎⴳⴰⵍ ⵏ ⵉⵣⵔⴼⴰⵏ ⵏ ⵓⵎⴳⴰⵢ ⵉⴽⵛⵎ ⴳ ⵓⵙⵎⵎⴰⵍ ⴰⴷ: (1) ⴰⵙⵏⵓⵎⵍ ⵏ ⵜⵡⵓⵔⵉ ⵉⵃⴱⴰⵏ ⵉⵣⵔⴼⴰⵏ ⵏ ⵓⵎⴳⴰⵢ ⵏⵏⴰ ⵉⴳⴰⵏ ⴰⵙⵏⵜⵍ ⵏ ⵓⵎⴳⴰⵍ; (2) ⴰⵙⵏⵓⵎⵍ ⵏ ⵜⵓⵎⴰⵢⵜ ⵉⵃⴱⴰⵏ ⵉⵣⵔⴼⴰⵏ ⴷ ⵉⵏⵖⵎⵉⵙⵏ ⵉⵅⵚⵚⴰⵏ ⴰⴼⴰⴷ ⴰⴷ ⵏⴰⴼ ⵜⵓⵎⴰⵢⵜ; (3) ⵉⵏⵖⵎⵉⵙⵏ ⵏ ⵓⵎⵢⴰⵡⴰⴹ ⴰⴽⴷⴽ, ⴳ ⵉⵍⵍⴰ ⵡⴰⵏⵙⴰ ⵏⵏⴽ, ⵓⵟⵟⵓⵏ ⵏ ⵜⵉⵍⵉⴼⵓⵏ ⴷ ⵡⴰⵏⵙⴰ ⵏ ⵓⵍⵉⴽⵜⵕⵓⵏ; (4) ⴰⵙⵉⵡⴹ ⵏⵏⴽ ⵎⴰⵙ ⴷⴰⵔⴽ ⵜⴰⵍⵍⵉⵍⵜ ⵉⵖⵓⴷⴰⵏ ⵏ ⵓⵙⵏⴽⴷ ⵎⴰⵙ ⵜⵓⵎⴰⵢⵜ ⵙ ⵜⵖⴰⵔⴰⵙⵜ ⵏⵏⴰ ⵜⵙⵙⵔⴳⴰⵍ ⵓⵔ ⵜⴽⴽⵉ ⵜⵓⵔⴰⴳⵜ ⵙⴳ ⵖⵓⵔ ⵡⴰⵏⵏⴰ ⵉⵟⵟⴰⴼⵏ ⵉⵣⵔⴼⴰⵏ ⵏ ⵓⵎⴳⴰⵢ, ⵏⵖⴷ ⴰⵎⴷⵢⴰⵣ ⵏⵏⵙ, ⵏⵖⴷ ⵙ ⵓⵙⵡⵓⵔⵉ ⵏ ⴽⵔⴰ ⵏ ⵓⵙⵍⴳⵏ; ']

['(5) ⴰⵙⵉⵙⵙⵉⴾⵉ ⵏⵢⵜ, ⵉⴾⴼⴰⵏ ⵙ ⴰⵍⵆⴰⴾⵓⵎ ⵏ ⴰⵍⵆⴰⴾⵓⵎ ⵏ ⵜⵉⴷⵉⵜ, ⴰⵙ ⵉⵙⴰⵍⴰⵏ ⵓⵉⵏ ⵢⵎⵢⵍ ⵏⴰⵙⴰⵏ ⵓⵉⵏ ⵢⵎⵢⵍ ⵓⵉⵏ ⴰⴾⴰⵉⴰⴷ ⴷ ⴰⵙ ⵉⵍⴰ ⴰⴾⴰⵉⴰⴷ ⵉ ⴰⵙⵓⵋ ⵏ ⴰⵍⵆⴰⴾⵓⵎ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜⵢⵏ ⵜⵉⵏ ⴰⴾⴰⵉⴰⴷ ⵓⵉⵏ ⴰⴾⴰⵉⴰⴷ ⵓⵉ ⴰⵋⵋⴰⵏⵢⵏ']

['ⴷ (6) ⴰⴾⴰⵔⵓⵙ ⵏ ⵉⴾⵉⵜⴱⴰⵏ ⵏ ⵎⵓⵙⵏⴰⵜ ⵏ ⵉⴾⵉⵜⴱⴰⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜ ⵎⵢⵗ ⵓⴰ ⵉⵋⵋⴰⵏ ⵙ ⵢⵎⵢⵍ ⵏ ⵎⵓⵙⵏⴰⵜ ⵏ ⵉⴾⵉⵜⴱⴰⵏ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜ']

['ⴰⴾⴰⵉⴰⴷ ⵏ ⴰⵙⴰⴾⵏⵢ ⵏ ⵉⵙⴰⵍⴰⵏ ⵓⵉⵏ ⴰⵋⵋⵓⵜⵏⵢⵏ ⴰⴷⴷⵓⴱⴰⵜ ⴰⴷ ⵢⵈⵈⵉⵍ ⴰⵙⵉⵓⴰⴷ ⵏ ⴰⴾⴰⵉⴰⴷ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜ ⵏ ⴰⵍⵆⵉⴷⵎⴰⵜ ⵏⵢⵜ']

['ⴰⵎⵢⴰⵡⴰⴹ']

['ⵙⵓⴾⵢⵍ ⵉⵢⵎⴰⵍ ⵉⵢⵎⴰ ⵙ ⴽⴰⴾⴰⵎⴰⵍ ⴰⵙⵉⵙⵜⴰⵏ/ⴰⵙⵓⵋ']

Who gets prostate cancer?

Prostate cancer is a disease that primarily affects men, with the risk increasing with age.

It is most commonly diagnosed in men over the age of 65.

Some factors that may increase the risk of developing prostate cancer include:

1. Age: The risk of prostate cancer increases with age, with most cases occurring in men over the age of 65.

2. Family history: Men with a family history of prostate cancer, particularly a father or brother with the disease, have a higher risk of developing prostate cancer themselves.

3. Race: African American men have a higher risk of developing prostate cancer and are more likely to be diagnosed at a younger age and with more aggressive forms of the disease.

4. Genetics: Certain inherited genetic mutations, such as those in the BRCA1 and BRCA2 genes, may increase the risk of developing prostate cancer.

5. Diet: A diet high in red meat and high-fat dairy products may increase the risk of prostate cancer, while a diet rich in fruits and vegetables may decrease the risk.

6. Obesity: Being overweight or obese may increase the risk of developing prostate cancer, as well as the likelihood of the cancer being more aggressive.

7. Lifestyle factors: Certain lifestyle factors, such as smoking and lack of physical activity, may increase the risk of developing prostate cancer.

It is important to note that while these factors may increase the risk of developing prostate cancer, not all men with these risk factors will develop the disease, and some men without any known risk factors may still be diagnosed with prostate cancer.

Regular screening and discussing any concerns with a healthcare provider can help to detect prostate cancer early, when it is most treatable.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.

['ⴰⵜⵜⴰⵢⵏ']

['ⴷⴰ ⵉⵙⵙⵎⵔⴰⵙ ⴱⵢⵓ ⵎⵉⴷⵍⵍⵉⴱ ⵉⵎⴰⵙⵙⵏ ⵏ ⵓⵙⵉⴳⴳⵍ ⵉⵎⵉⴽⵙⵉⵍⵏ (ⴰⵍⴳⵓⵔⵉⵜⵎ ⵏ ⵓⵍⵎⵎⵓⴷ ⵏ ⵉⵎⵉⵙ) ⵉ ⵓⵙⵓⴼⵖ ⵏ ⵉⵎⵣⵉⵏⵏ ⵏ ⵉⵙⵇⵙⵉⵜⵏ ⴷ ⵜⵎⵔⴰⵔⵓⵜⵉⵏ.']

['ⴷⴰ ⵏⵙⵙⵏⵜⵉ ⵙ 35 ⵎⵍⵢⵓⵏ ⵏ ⵜⵥⵕⵉⴳⵉⵏ ⵏ ⵜⵙⵏⵉⵊⵊⵉⵜ ⵜⴰⴱⵢⵓⵎⵉⴷⵉⴽⵜ ⵏ ⴱⴰⴱⵎⵉⴷ/ⵎⵉⴷⵍⵉⵏ. ⵓⵍⴰ ⴰⵡⴷ ⵜⵉⴼⵔⴽⵉⵏ ⵏ ⵡⵉⴱ ⵏ ⵔⴰⴼⵉⵏⴷⵡⵉⴱ.']

['ⴰⵜ-ⵓ-ⴰⵗ "ⴰⵍⵓⴰⵈⴰⵏ" ⴰⴷ "ⴰⴾⴼⴰⵣ"']